ATHX Athersys Inc

Athersys Inc is a biopharmaceutical company engaged in the discovery and development of therapeutic product candidates designed to extend and improve the quality of human life.

As of 12/06/2021     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  06/12/2007
Outstanding shares:  235,235,247
Average volume:  2,552,342
Market cap:   $256,406,419
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    04744L106
ISIN:        US04744L1061
Sedol:      B1YH8W1
Valuation   (See tab for details)
PE ratio:   -3.74
PB ratio:   8.24
PS ratio:   100.76
Return on equity:   -297.99%
Net income %:   -3,436.43%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy